• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

BBS-Bioactive Bone Substitutes

3,878 following
Overview
Ownership
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
I requested the bankruptcy documents for BBS Oyj from the district court out of pure curiosity a few weeks ago, and I thought I’d share a few words about them here. According to the inventory of the estate dated February 17, 2025, the value of the company’s assets was estimated at...
4/28/2026, 9:25 PM
8
Yes, the matter can also be monitored to some extent through public services. The Finnish Patent and Registration Office maintains the Virre information service, from which you can obtain the latest trade register extract: https://virre.prh.fi/novus/home?execution=e2s1 Once insolvency...
11/13/2025, 1:30 PM
by Pohjolan Eka
4
A long-term project to sell bits and bobs, lab gear is still being auctioned off. https://realisointihuutokauppa.fi/tuote/laboratorio-tarvikkeita-bbs17/
1/19/2026, 3:27 PM
by WilunGi
3
How do you lose those from the equity savings account? The row still haunts there…
4/2/2026, 5:08 PM
by tomtom
2
““““““ BBS-BIOACTIVE BONE SUBSTITUTES OYJ:N BANKRUPTCY CERTIFICATE TO SHAREHOLDERS ““““““““ On the Kauppalehti forum, a user contacted a law firm. They received a certificate for shareholders in response; no distribution share. The user entered 10.11.2025 as the disposal date for...
4/2/2026, 4:03 PM
by j.sälli
2
Now the property is up for sale as well. huutokaupat.com Kiinteistö rakennuksineen, teollisuus- ja varastorakennus, Reisjärvi |... MYYTÄVÄ KOHDE Reisjärven kunnassa, asemakaavoitetulla alueella sijaitseva kiinteistö ja sillä sijaitseva teollisuusrakennus osoitteessa Teollisuustie...
4/20/2026, 6:02 AM
by Ysiysitoista
1
The bankruptcy estate seems to be auctioning off assets again, this time here: https://realisointihuutokauppa.fi/?filter=suosituimmat&city=Reisjärvi&konkurssipesa=BBS-Bioactive%20Bone%20Substitutes%20Oyj%20konkurssipesä%20(0866451-4) Can the estate administration be followed from...
11/13/2025, 8:03 AM
by tomtom
1
Read more on our forum
Regulatory press release3/5/2025, 12:30 PM

BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North

BBS-Bioactive Bone Substitutes
Regulatory press release2/20/2025, 7:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/17/2025, 11:15 AM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt

BBS-Bioactive Bone Substitutes

Join Inderes community

Research, tools and community to support better investment decisions.

FREE account
The market's most popular morning review
Analysts' recommendations and comments
Stock comparison and the investor discussion forum
PREMIUM account
All company reports and analyses
Premium content: model portfolio, insider transactions, Premium articles
Inderes MCP: Inderes data directly into your AI tools
Create account
Regulatory press release2/12/2025, 3:00 PM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/10/2025, 7:00 AM

BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations

BBS-Bioactive Bone Substitutes
Regulatory press release2/6/2025, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release1/31/2025, 2:30 PM

BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 12:00 PM

Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 7:30 AM

BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations

BBS-Bioactive Bone Substitutes
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video12/2/2024, 2:00 PM

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatory press release11/29/2024, 2:30 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 2:20 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release11/26/2024, 3:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:05 PM

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:00 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations

BBS-Bioactive Bone Substitutes
Regulatory press release11/14/2024, 12:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/7/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes